23.67USD-0.25%Mkt Cap: 1.41B $P/E: —1d ago
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a …
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
CRY
GraniteShares YieldBOOST CRCL ETF—
Indicators:|
Key Statistics
Company
Market Cap1.41B $
Enterprise Value1.20B $
Revenue (TTM)283.30M $
Gross Profit170.94M $
Net Income (TTM)-12.78M $
Revenue/Share5.745 USD
Last Price23.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees943
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)49.96
PEG—
EV/EBITDA-445.54
EV/Revenue4.23
P/S4.97
P/B5.99
EPS (TTM)-0.23
EPS (Forward)0.47
52W Range
10.2880% of range26.92
52W High26.92 USD
52W Low10.28 USD
Profitability
Gross Margin65.69%
Oper. Margin-6.13%
EBITDA Margin-0.95%
Profit Margin-4.91%
ROE-5.56%
ROA-4.18%
Growth
Revenue Growth42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.25M $
CapEx (TTM)5.83M $
FCF Margin5.93%
FCF Yield1.19%
Net Debt-211.76M $
Net Debt/EBITDA78.69
Balance Sheet
Debt/Equity0.00
Current Ratio3.92
Quick Ratio3.69
Book Value/Sh3.952 USD
Cash/Share3.562 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.18 USD
Upside (mean)-2.1%
Target Range15.00 USD – 30.00 USD
$15.00-2.1% to mean$30.00
# Analysts11
Ownership
Shares Out.59.45M
Float46.84M
Insiders2.18%
Institutions81.71%
Short Interest
Short Ratio7.0d
Short % Float13.36%
Short % Out.13.11%
Shares Short7.79M
Short (prev mo.)6.99M
Technical
SMA 5018.50 (+28.0%)
SMA 20017.15 (+38.1%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)1.11M
Avg Vol (10d)1.19M
Technical Indicators
RSI (14)77.9
MACD1.6189
MACD Signal1.5569
MACD Hist.+0.0620
BB Upper26.10 USD
BB Middle21.41 USD
BB Lower16.72 USD
BB Width43.78%
ATR (14)0.9857 USD
Vol Ratio (20d)1.14x